News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,539 Results
Type
Article (43118)
Company Profile (290)
Press Release (656131)
Section
Business (207113)
Career Advice (2031)
Deals (35877)
Drug Delivery (84)
Drug Development (81023)
Employer Resources (168)
FDA (16664)
Job Trends (15172)
News (350249)
Policy (33610)
Tag
Academia (2584)
Alliances (49842)
Alzheimer's disease (1230)
Approvals (16580)
Artificial intelligence (117)
Bankruptcy (356)
Best Places to Work (11567)
Biotechnology (202)
Breast cancer (106)
Cancer (900)
Cardiovascular disease (80)
Career advice (1699)
Cell therapy (199)
Clinical research (64090)
Collaboration (328)
Compensation (168)
COVID-19 (2532)
Cystic fibrosis (78)
Data (857)
Diabetes (133)
Diagnostics (6173)
Earnings (85202)
Employer resources (146)
Events (110796)
Executive appointments (247)
FDA (17114)
Funding (291)
Gene therapy (148)
GLP-1 (559)
Government (4398)
Healthcare (18908)
Infectious disease (2606)
Inflammatory bowel disease (102)
Interviews (313)
IPO (16441)
Job creations (3896)
Job search strategy (1455)
Layoffs (411)
Legal (8153)
Lung cancer (154)
Manufacturing (150)
Medical device (14055)
Medtech (14060)
Mergers & acquisitions (19450)
Metabolic disorders (360)
Neuroscience (1474)
NextGen Class of 2024 (6647)
Non-profit (4491)
Northern California (1206)
Obesity (215)
Opinion (179)
Patents (95)
People (57063)
Phase I (19879)
Phase II (28225)
Phase III (21067)
Pipeline (207)
Postmarket research (2560)
Preclinical (8455)
Radiopharmaceuticals (235)
Rare diseases (178)
Real estate (6072)
Regulatory (22242)
Research institute (2345)
Resumes & cover letters (353)
Southern California (1089)
Startups (3716)
United States (11722)
Vaccines (540)
Weight loss (157)
Date
Today (171)
Last 7 days (812)
Last 30 days (2833)
Last 365 days (36042)
2024 (30577)
2023 (40452)
2022 (51577)
2021 (56213)
2020 (54689)
2019 (47322)
2018 (35670)
2017 (32990)
2016 (32696)
2015 (38720)
2014 (32437)
2013 (27586)
2012 (29812)
2011 (30439)
2010 (28447)
Location
Africa (749)
Arizona (191)
Asia (38534)
Australia (6236)
California (2738)
Canada (1173)
China (210)
Colorado (120)
Connecticut (124)
Europe (82032)
Florida (392)
Georgia (99)
Illinois (314)
Indiana (178)
Kansas (95)
Maryland (529)
Massachusetts (2220)
Michigan (143)
Minnesota (255)
New Jersey (823)
New York (838)
North Carolina (696)
Northern California (1206)
Ohio (125)
Pennsylvania (745)
South America (1132)
Southern California (1089)
Texas (386)
Utah (81)
Washington State (322)
699,539 Results for "908 devices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
908 Devices to Participate in Upcoming Investor Conferences
November 4, 2024
·
1 min read
Genetown
908 Devices to Participate in Upcoming Investor Conferences - May 15, 2024
908 Devices Inc. today announced it will participate in the following investor conferences.
May 15, 2024
·
1 min read
Business
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
908 Devices Inc. has appointed Michele M. Leonhart, the former Administrator of the United States Drug Enforcement Administration (DEA), to serve on its Board of Directors effective immediately.
June 25, 2024
·
4 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Business
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
908 Devices Inc. today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024.
April 23, 2024
·
1 min read
Genetown
908 Devices to Participate in Upcoming Investor Conferences - February 22, 2024
908 Devices Inc. today announced it will participate in the following investor conferences.
February 22, 2024
·
1 min read
Business
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook.
April 30, 2024
·
7 min read
Genetown
908 Devices Announces MX908 Integration Capabilities
908 Devices Inc. announced that it has expanded access to its leading trace detection technology in its handheld MX908 device through the addition of a weatherproof, digital communications port, thereby enabling companies to integrate the device into their systems to enhance the safety of their users and the public.
November 14, 2023
·
5 min read
Business
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, reported financial results for the quarter and full year ended December 31, 2023.
March 5, 2024
·
8 min read
Business
908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the fourth quarter and full year 2023 before market open on Tuesday, March 5, 2024.
February 20, 2024
·
1 min read
1 of 69,954
Next
